Designing spatial and temporal control of vaccine responses

GA Roth, VCTM Picece, BS Ou, W Luo… - Nature Reviews …, 2022 - nature.com
Vaccines are the key technology to combat existing and emerging infectious diseases.
However, increasing the potency, quality and durability of the vaccine response remains a …

B cell responses: cell interaction dynamics and decisions

JG Cyster, CDC Allen - Cell, 2019 - cell.com
B cells and the antibodies they produce have a deeply penetrating influence on human
physiology. Here, we review current understanding of how B cell responses are initiated; the …

Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines

J Lee, MC Woodruff, EH Kim, JH Nam - Experimental & Molecular …, 2023 - nature.com
Since the discovery of messenger RNA (mRNA), there have been tremendous efforts to
wield them in the development of therapeutics and vaccines. During the COVID-19 …

Germinal centers

GD Victora, MC Nussenzweig - Annual review of immunology, 2022 - annualreviews.org
Germinal centers (GCs) are microanatomical sites of B cell clonal expansion and antibody
affinity maturation. Therein, B cells undergo the Darwinian process of somatic diversification …

Antigen-and scaffold-specific antibody responses to protein nanoparticle immunogens

JC Kraft, MN Pham, L Shehata, M Brinkkemper… - Cell Reports …, 2022 - cell.com
Protein nanoparticle scaffolds are increasingly used in next-generation vaccine designs,
and several have established records of clinical safety and efficacy. Yet the rules for how …

Protein engineering strategies for rational immunogen design

TM Caradonna, AG Schmidt - npj Vaccines, 2021 - nature.com
Antibody immunodominance refers to the preferential and asymmetric elicitation of
antibodies against specific epitopes on a complex protein antigen. Traditional vaccination …

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

AD Nahmad, Y Raviv, M Horovitz-Fried, I Sofer… - Nature …, 2020 - nature.com
ABSTRACT HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially
single-shot alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly …

Factors in B cell competition and immunodominance

RK Abbott, S Crotty - Immunological reviews, 2020 - Wiley Online Library
The majority of all vaccines work by inducing protective antibody responses. The
mechanisms by which the B cells responsible for producing protective antibodies are elicited …

B cell responses against influenza viruses: short-lived humoral immunity against a life-long threat

JJ Guthmiller, HA Utset, PC Wilson - Viruses, 2021 - mdpi.com
Antibodies are critical for providing protection against influenza virus infections. However,
protective humoral immunity against influenza viruses is limited by the antigenic drift and …

Cocktail anti-tick vaccines: The unforeseen constraints and approaches toward enhanced efficacies

C Ndawula Jr, AE Tabor - Vaccines, 2020 - mdpi.com
Ticks are second to mosquitoes as vectors of disease. Ticks affect livestock industries in
Asia, Africa and Australia at~ 1.13billionUSDperannum.Forinstance,80%oftheglobalcattlepopulationisatriskofinfestati …